And with microplastics discovered in the brain, reproductive organs, liver, kidneys, lungs, and even bloodstream of people ...

Argenica Therapeutics (ASX:AGN) has achieved another important step in the progression of its Phase 2 trial to assess drug ...

The world-first IV-administered psychedelic trial for binge eating disorder will kick off this year, as Swinburne University ...

Trends & Forecast 2022-2032The global IV infusion gravity bags market is experiencing remarkable growth, fueled by the increasing need for efficient fluid delivery systems in healthcare settings.

San Clemente, California Wednesday, April 9, 2025, 11:00 Hrs [IST] ...

Infusion therapy is a medical treatment where fluids, medications, or nutrients are delivered directly into a patient’s ...

IRadimed Corporation offers steady revenue growth with 14 consecutive quarters of record revenue and a small dividend, ...

ICU Medical (Nasdaq: ICUI) announced today that it received FDA 510(k) clearance for several new additions to its infusion ...

Inebilizumab-cdon was previously approved by the FDA for neuromyelitis optica spectrum disorder (NMOSD) in adults who are ...

The Company anticipates filing its NDA for GTx-104 in the second quarter of 2025. Acceptance of the NDA will be subject to the FDA’s review of the complete filing.

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...